DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Rakic JM, Leys A, Brie H. et al.
Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study.
Clin Ophthalmol 2013;
7: 1849-1858
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.